CD79A and myeloid sarcoma: Others have observed trends for reduced diversity among individuals with MS, with a few more clinically homogeneous cohorts reaching statistical significance.28 We observed no differences in α- and β-diversity among IgA+ and IgA– bacterial fractions, suggesting that microbial diversity remains stable despite changes in immune coatings to gut bacteria.